The number of remotely monitored patients has reached 76.7 million worldwide in 2023 as the market acceptance for mHealth solutions grew in several key verticals.
This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen. Connected medical devices used for personal health tracking are not included in this analysis. The number of remotely monitored patients will grow at a CAGR of 12.8 percent to reach 140.1 million by 2028, research firm Berg Insight estimates.
The three main applications are monitoring of patients with sleep therapy devices, glucose level monitoring of patients with diabetes and monitoring of patients with implantable cardiac rhythm management (CRM) devices.
Sleep therapy is by far the most connected segment, dominated by ResMed. In 2023, 32.2 million sleep therapy patients were remotely monitored. The growth is largely driven by the compliance monitoring requirements introduced in the US and across European countries.
Glucose level monitoring is the second largest segment with 12.6 million connections at the end of the year. The growth is driven by the increased adoption of continuous glucose monitoring (CGM) systems from providers such as Abbott and Dexcom.
The CRM market is led by companies such as Medtronic, Abbott, Boston Scientific and BIOTRONIK that started to include connectivity in CRM solutions more than two decades ago. Other device categories include ECG, telehealth, medication compliance, blood pressure monitors and others.
The fastest growing market segments in the next five years are anticipated to be remote ECG monitoring and medication compliance monitoring.
Connected healthcare players in these segments include forward-thinking incumbents as well as new entrants such as AliveCor, Boston Scientific, Compliance Meds Technologies, Evondos, GE HealthCare, Phillips, Hero, InfoBionic.Ai, iRhythm Technologies, MedMinder, MedReady and VitalConnect.
mHealth software and services are one of the most rapidly developing parts of the mHealth value chain. This segment includes platforms and software solutions that enable remote patient monitoring by utilizing connected devices like wearables and sensors to collect vital signs data and health metrics in real-time.
Service providers in this space offer comprehensive solutions that integrate data analytics, telehealth capabilities and patient engagement tools to ensure continuous and efficient care.
Companies that specialise in this area include Accuhealth, Amwell, Aptar Digital Health, Alira Health (Bepatient), Biofourmis, Doccla, Huma Therapeutics, Omron Healthcare (Luscii), Medixine, Medisanté, MedM, S3 Connected Health, Current Health, SHL Telemedicine, Teladoc Health (Livongo), TytoCare, Enovation and Welldoc.
“With advancements in AI and machine learning, mHealth platforms are evolving from monitoring tools to comprehensive systems that assist in diagnosing and treating patients, paving the way for more effective healthcare,” says Vatsala Raina, IoT Analyst at Berg Insight.
